Showing results (61-70 of 331) with videos related to
Sort By:
Pageof 34
Journal of Neurology|October 20, 2020
Digital biomarkers can highlight subtle clinical differences in radiologically isolated syndrome compared to healthy controlsMikael Cohen, Lydiane Mondot, Salim Fakir, et al.Multiple Sclerosis and Related Disorders|July 22, 2023
Towards a more precise rating of neurological disability in multiple sclerosis: A new automatic and linear quantification of limbs functionMikael Cohen, Lydiane Mondot, Cassandre Landes-Chateau, et al.Neurology and Therapy|May 23, 2015
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical PracticeMuriel Laffon, Grégoire Malandain, Heloise Joly, et al.Neurology and Therapy|May 23, 2015
A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treatingChristine Lebrun, Mikael Cohen, Annabelle Chaussenot, et al.Clinical Neurology and Neurosurgery|August 16, 2011
Endermology: a treatment for injection-induced lipoatrophy in multiple sclerosis patients treated with sub cutaneous glatiramer acetateChristine Lebrun, Lydiane Mondot, Marc Bertagna, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 14, 2012
Increased risk of multiple sclerosis relapse after in vitro fertilisationLaure Michel, Yohann Foucher, Sandra Vukusic, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 27, 2021
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With NatalizumabNicolás Fissolo, Beatrice Pignolet, Jordi Rio, et al.Pathologie-Biologie|February 15, 2005
[Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis]Christiane Caudie, Al Medhi Birouk, Julien Bancel, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 11, 2023
Vaccine response in people with multiple sclerosis treated with fumaratesMatthew A Tremblay, Sandra Vukusic, Mathura Shanmugasundaram, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2023
Pseudocystic inflammatory demyelinating lesions in multiple sclerosis: A clinical, radiological, and pathological descriptionFlorent Cluse, Tanguy Fenouil, Sandra Vukusic, et al.Pageof 34